Mutations in three key genes associated with poor outcomes in lung cancer patients treated with KRAS G12C inhibitors
A new study led by researchers at The University of Texas MD Anderson Cancer Center has discovered that co-occurring mutations in three tumor suppressor genes—KEAP1, SMARCA4 and CDKN2A—are linked with poor clinical outcomes ...
Apr 17, 2023
0
5